Vos Ellen O'Connor bought OPRX
June 9, 2026 · Form 4 insider transaction
Vos Ellen O'Connor bought 34,517 shares of OptimizeRx Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
34,517
Price
$0.00
Total value
N/A
InsiderVos Ellen O'Connor
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 10, 2026
Shares owned after107,159
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.